PLUS1
Best deals to access real time data! |
|
Real-time Level 1 for London Stock Exchange
Monthly Subscription
for only
$29.56
|
|
London Stock Exchange Level 2
Monthly Subscription
for only
$77.61
|
|
Real-time London Stock Exchange & FTSE
Monthly Subscription
for only
$88.69
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type | ISIN | Company Description |
|---|---|---|---|---|---|
| Glaxosmithkline | GSK | London | Ordinary Share | GB0009252882 | ORD 25P |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 8.20 | 0.50% | 1,654.60 | 1,662.00 | 1,639.20 | 1,646.40 | 1,646.40 | 11:35:28 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 1,652.60 | 1,653.20 | 0.60 | 0.04% | 1 | 3 |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 7,842 | 5,355,004 | 1,654.01p | 88,572,457p | - | 1,408.80 - 1,672.00 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 13:28:10 | O | 502 | 1,653.44p | GBX |
| Industry Sector |
|---|
| PHARMACEUTICALS & BIOTECHNOLOGY |
Glaxosmithkline Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| 81.73Bp | - | - | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | -p | 0.00% | - | - |
Glaxosmithkline News
| Date | Time | Source | News Article |
|---|---|---|---|
| 7/22/2019 | 12:52 | Dow Jones News | GlaxoSmithKline's ViiV Healthcare Finds Positive Data In HIV.. |
| 7/22/2019 | 12:19 | Alliance News |  GlaxoSmithKline's ViiV Healthcare Gets Positive Fostemsavir.. |
| 7/22/2019 | 12:00 | UK Regulatory (RNS & others) | GlaxoSmithKline PLC ViiV presents 96-week data from phase.. |
| 7/15/2019 | 13:19 | UK Regulatory (RNS & others) | GlaxoSmithKline PLC Director/PDMR Shareholding |
| 7/15/2019 | 13:18 | UK Regulatory (RNS & others) | GlaxoSmithKline PLC Director/PDMR Shareholding |
| 7/15/2019 | 13:16 | UK Regulatory (RNS & others) | GlaxoSmithKline PLC Director/PDMR Shareholding |
| 7/15/2019 | 06:42 | UK Regulatory (RNS & others) | GlaxoSmithKline PLC Director/PDMR Shareholding |
Glaxosmithkline Discussion Forums - GSK
| Date | Time | Comments | Title |
|---|---|---|---|
| 12/19/2018 | 04:42 | - | Yep 39 now with 5% divvy I don''t |
| 12/19/2018 | 04:18 | - | GSK, PFE form consumer-health JV: #msg-145552190. |
| 12/19/2018 | 04:10 | - | I agree with your theory completely make total sense. |
| 6/13/2018 | 03:33 | - | Novartis'' Entresto is nothing more than an attempt |
| 3/04/2018 | 09:40 | - | Buy anything below 36 not much down side risk. |
| 2/08/2018 | 10:04 | - | Copy of Presentation: |
| 2/07/2018 | 07:50 | - | GSK 4Q17 CC slides: |
| 10/23/2017 | 05:30 | - | https://seekingalpha.com/article/4115400-glaxosmithkline-lands-big-win-shingles- |
| 9/13/2017 | 07:32 | - | [b]Mymetics to Present New Preclinical Data on Thermostable |
| 8/11/2017 | 05:08 | - | Breakthrough in vaccine delivery will disrupt the vaccine |
Historical GSK Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol [m] | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1,618 | 1,672 | 1,614.4 | 1,652.8214 | 9M | 36.6 | 2.26% |
| 1 Month | 1,577.6 | 1,672 | 1,564.8 | 1,626.5218 | 8M | 77 | 4.88% |
| 3 Months | 1,567.2 | 1,672 | 1,495.4 | 1,579.1147 | 8M | 87.4 | 5.58% |
| 6 Months | 1,496.8 | 1,672 | 1,429.8 | 1,555.0613 | 8M | 157.8 | 10.54% |
| 1 Year | 1,567.2 | 1,672 | 1,408.8 | 1,539.4814 | 9M | 87.4 | 5.58% |
| 3 Years | 1,638.5 | 1,735.5 | 1,236.4 | 1,523.2728 | 9M | 16.1 | 0.98% |
| 5 Years | 1,558.5 | 1,735.5 | 1,227.5 | 1,484.2275 | 9M | 96.1 | 6.17% |
